Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 July 2020 | Story Valentino Ndaba
Add these emergency safety contacts to your speed dial.

Staying safe during the coronavirus pandemic extends to ensuring that students at the University of the Free State (UFS) are safe from crime. Crime in South Africa remains an unfortunate reality which continues to affect students, staff and the institution in general. 

“Crime requires constant vigilance from the community and this can only be achieved through initiatives that are aimed at informing the community on what to do and what not to do. To this end the BSafe Safety First flyer is geared at informing specifically the student community on safety measures that must be taken,” said Cobus van Jaarsveld, Assistant Director: Threat Detection, Investigations and Liaison at Protection Services.

The Safety First flyer is a guide for students to be crime-conscious whether at their accommodation, on the street, or in their vehicles. It also offers tips on how to act responsibly as far as alcohol and drugs are concerned.

Engaging students on their safety 

UFS Protection Services recently engaged with off-campus residence students in Bloemfontein in order to provide tips on how to stay safe in their neighbourhoods. During the engagement, the new Safety First pamphlets were distributed, and students were encouraged to join the Student Crime-Stop Brandwag WhatsApp group.

As from 15 June 2020, Nissi Armed Response was deployed from 18:00 to 06:00. This initiative has already led to them responding to several suspicious persons and vehicles, as well as some minor incidents and disturbances. Two arrests were made on different occasions as a result of the deployment. In the first incident, a suspect was arrested on 27 June 2020 after a burglary in Brandwag, and the second relates to a suspect who was arrested on 10 July 2020 after threatening students at Universitas.

These successes were the result of student and community participation in providing information, coupled with excellent response from private security companies, including Nissi Armed Response, VR Security, and BloemSec.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept